Drugs that contain Olopatadine Hydrochloride

1. List of Pataday Once Daily Relief drug patents

PATADAY ONCE DAILY RELIEF Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8791154 ALCON LABS INC High concentration olopatadine ophthalmic composition
May, 2032

(9 years from now)

US9533053 ALCON LABS INC High concentration olopatadine ophthalmic composition
May, 2032

(9 years from now)

Market Authorisation Date: 30 January, 2015

Treatment: Treatment of ocular itching associated with allergic conjunctivitis

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of PATADAY ONCE DAILY RELIEF before it's patent expiration?
More Information on Dosage

PATADAY ONCE DAILY RELIEF family patents

6

United States

4

Korea, Republic of

2

China

2

European Union

1

South Africa

1

Mexico

1

Australia

1

Hong Kong

1

Russia

1

Uruguay

1

Argentina

1

Colombia

1

Brazil

1

Spain

1

Chile

1

Taiwan, Province of China

1

Ukraine

1

Japan

1

Canada

2. List of Patanase drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8399508 NOVARTIS Olopatadine formulations for topical nasal administration
Sep, 2022

(6 months ago)

US7977376 NOVARTIS Olopatadine formulations for topical nasal administration
Feb, 2023

(a month ago)

US8399508

(Pediatric)

NOVARTIS Olopatadine formulations for topical nasal administration
Mar, 2023

(10 days ago)

US7977376

(Pediatric)

NOVARTIS Olopatadine formulations for topical nasal administration
Aug, 2023

(4 months from now)

Market Authorisation Date: 15 April, 2008

Treatment: Allergic rhinitis

Dosage: SPRAY, METERED;NASAL

How can I launch a generic of PATANASE before it's patent expiration?
More Information on Dosage

PATANASE family patents

6

United States

5

Japan

1

South Africa

1

Denmark

1

Austria

1

Mexico

1

Australia

1

Hong Kong

1

Germany

1

Argentina

1

Brazil

1

Portugal

GC

1

GC

1

Spain

1

Korea, Republic of

1

Poland

1

Taiwan, Province of China

1

China

1

Canada

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in